Press Release
Valeant (NYSE: VRX) and Biovail (NYSE/TSX: BVF) today announced that both companies’ Boards of Directors have unanimously approved a definitive merger agreement under which the companies would combine to generate enhanced value for stockholders.

[affmage source="amazon" results="2"]skadden arps advisor[/affmage]